Competitive Price for 3-Amino-4-Pyrazolecarboxamidehemisulfate - Desmopressin Acetate to Treat central Diabetes Insipidus – Gentolex

Short Description:

Send email to us

Product Detail

Product Tags

Feedback (2)

We are commitment to offer the competitive price ,outstanding products quality, as well as fast delivery for Tri Acetate, Ammonium Acetate, Octreotide, Seeing believes! We sincerely welcome the new customers abroad to set up business relationships and also expect to consolidate the relationships with the long-established customers.

Competitive Price for 3-Amino-4-Pyrazolecarboxamidehemisulfate - Desmopressin Acetate to Treat central Diabetes Insipidus – Gentolex Detail:

Product Detail

Name	Desmopressin
CAS number	16679-58-6
Molecular formula	C46H64N14O12S2
Molecular weight	1069.22
EINECS Number	240-726-7
Specific rotation	D25 +85.5 ± 2° (calculated for the free peptide)
Density	1.56±0.1 g/cm3(Predicted)
RTECS No.	YW9000000
Storage conditions	Store at 0°C
Solubility	H2O:soluble20mg/mL, clear, colorless
Acidity coefficient	(pKa) 9.90±0.15 (Predicted)

Synonyms

MPR-TYR-PHE-GLN-ASN-CYS-PRO-D-ARG-GLY-NH2; MINIRIN; [DEAMINO1, DARG8] VASOPRESSIN; [DEAMINO-CYS1, D-ARG8]-VASOPRESSIN; DDAVP, HUMAN; DESMOPRESSIN; DESMOPRESSIN, HUMAN; DESAMINO-[D-ARG8] VASOPRESSIN

Indications

(1) Treatment of central diabetes insipidus. After the drug can reduce urinary excretion, reduce urinary frequency and reduce nocturia.

(2) Treatment of nocturnal enuresis (patients aged 5 years or older).

(3) Test the renal urine concentration function, and carry out the differential diagnosis of renal function.

(4) For hemophilia and other bleeding diseases, this product can shorten the bleeding time and prevent bleeding. It can reduce the amount of intraoperative blood loss and postoperative oozing; especially in conjunction with reasonably controlled blood pressure during surgery, it can reduce intraoperative bleeding from different mechanisms, and reduce postoperative oozing, which can play a better role in blood protection.

Treatment of diabetes insipidus

Diabetes insipidus is primarily a disorder of water metabolism characterized by excess urine output, polydipsia, hypoosmolarity, and hypernatremia. Partial or complete deficiency of vasopressin (central diabetes insipidus), or renal insufficiency of vasopressin (nephrogenic diabetes insipidus) can be onset. Clinically, diabetes insipidus is similar to primary polydipsia, a condition in which excessive fluid intake is caused by a malfunction of the regulatory mechanism or abnormal thirst. Contrary to primary polydipsia, the increase in water intake in patients with diabetes insipidus is a corresponding response to changes in osmotic pressure or blood volume.

Product detail pictures:

Related Product Guide:

"Based on domestic market and expand overseas business" is our development strategy for Competitive Price for 3-Amino-4-Pyrazolecarboxamidehemisulfate - Desmopressin Acetate to Treat central Diabetes Insipidus – Gentolex , The product will supply to all over the world, such as: South Korea, Barbados, Congo, We've a skilled sales team, they have mastered the best technology and manufacturing processes, have years of experience in foreign trade sales, with customers able to communicate seamlessly and accurately understand the real needs of customers, providing customers with personalized service and unique merchandise.

Andarine